Global Type-2 Diabetes Market Research Report: Forecast (2025-2030)

Name: Global Type-2 Diabetes Market Research Report: Forecast (2025-2030)
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

Type-2 Diabetes Market - By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodiu ... m-Glucose Cotransporter 2 Inhibitors (SGLT2), Sulfonylureas, Other (Thiazolidinediones, Meglitinides, Glitazones, etc.), By Gender Type (Male, Female), By Age Group (Upto 19 Years, 20 – 65 Year, Above 65), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (U.S., Canada, Mexico, Brazil, Argentina, U.K., Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, India, Japan, South Korea, Australia, South East Asia), By Comany (Merck & Co, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson), and others. Read more

Healthcare
May 2025
Pages 178
Report Format: PDF, Excel, PPT

Download Free Sample

Market Definition

Diabetes is a chronic metabolic disease marked by elevated levels of blood glucose (or blood sugar) that results in severe damage to the kidneys, heart, blood vessels, eyes, and nerves over time. Broadly, there are two types of diabetes, Type-1, and Type-2. Type 2 diabetes, usually common in adults, occurs when the body doesn't make enough insulin or becomes resistant to it.

Market Insights & Analysis: Global Type-2 Diabetes Market (2025-30):

The Global Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30.

The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year. The number of cases and the prevalence of diabetes have witnessed expansion over the past few decades. In addition, the rising geriatric population, along with the surging population with type-1 diabetes and the lack of proper healthcare infrastructure in emerging countries, are projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.

Report Coverage	Details
Historical Years	2020–23
Base Years	2024
Forecast Years	2025–30
Market Value in 2024	USD 52.7 Billion
Market Value by 2030	USD 72.21 Billion
CAGR (2025–30)	5.39%
Leading Region	North America
Top Key Players	Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson, and others
Segmentation	By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2), Sulfonylureas, Other (Thiazolidinediones, Meglitinides, Glitazones, etc.), By Gender Type (Male, Female), By Age Group (Upto 19 Years, 20 – 65 Year, Above 65), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (U.S., Canada, Mexico, Brazil, Argentina, U.K., Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, India, Japan, South Korea, Australia, South East Asia), By Comany (Merck & Co, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson), and others.
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Key players such as AstraZeneca, Pfizer, Johnson & Johnson, etc., bring forth innovative medical devices to aid diabetic patients. Besides, to gain a competitive edge over the other market players and have a strong foothold worldwide, these companies are collaborating with other pharmaceutical firms to launch products in other markets. Moreover, to make the diabetes digital health space less congested, the companies have entered the digital market by launching mobile health apps for the customer to ease them by constantly tracking their type 2 diabetes regimes. These aspects are likely to accentuate the market expansion in the coming years.

Global Type-2 Diabetes Market Driver:

Rising Global Prevalence of Obesity and Sedentary Lifestyle – A key driver for the Global Type-2 Diabetes Market is the increasing prevalence of obesity and sedentary lifestyles worldwide. Urbanization, changing dietary habits, and reduced physical activity are leading to a surge in obesity rates, which is a major risk factor for type 2 diabetes. This trend is particularly pronounced in both developed and developing nations, contributing to a growing patient pool and heightened demand for diabetes management solutions. As more individuals are diagnosed with type 2 diabetes, the market for medications, monitoring devices, and support services continues to expand rapidly.

Global Type-2 Diabetes Market Opportunity:

Development of Personalized Medicine and Advanced Therapies – A major opportunity in the market lies in the development of personalized medicine and advanced therapies for type-2 diabetes. Advances in genomics, biomarker research, and drug delivery systems are enabling tailored treatment plans that address individual patient needs and genetic profiles. Pharmaceutical companies investing in precision medicine and innovative drug formulations can offer more effective and safer therapies, catering to diverse patient populations. This approach not only improves clinical outcomes but also opens new revenue streams and differentiates offerings in a highly competitive market.

Global Type-2 Diabetes Market Challenge:

High Cost and Limited Access to Advanced Treatments – A significant challenge facing the Global Type-2 Diabetes Market is the high cost and limited access to advanced treatments, especially in low- and middle-income countries. While new drugs and technologies offer improved disease management, their affordability and availability remain major barriers for many patients. Inadequate healthcare infrastructure, insurance coverage gaps, and economic disparities further exacerbate the issue, leading to suboptimal treatment and increased disease burden. Addressing these challenges is crucial for ensuring equitable care and sustaining market growth worldwide.

Global Type-2 Diabetes Market Trend:

Adoption of Digital Health and Remote Monitoring Solutions – A prominent trend in the Type-2 Diabetes Market is the adoption of digital health technologies and remote monitoring solutions. Patients and healthcare providers are increasingly utilizing mobile apps, wearable devices, and telemedicine platforms to track blood glucose levels, manage medication adherence, and receive personalized health recommendations. These innovations are improving disease management, patient engagement, and early intervention, while also reducing the burden on healthcare systems. The integration of digital tools is transforming traditional diabetes care into a more proactive and patient-centered approach.

Global Type-2 Diabetes Market (2025-30): Segmentation Analysis

The Global Type-2 Diabetes Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2025–2030 at the global level. Based on the analysis, the market has been further classified as:

Based on Gender:

Male
Female

Between the two, the female segment held a significant market share in the Global Type-2 Diabetes market in 2024, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women. Due to multiple adverse pregnancy outcomes, the development of gestational diabetes is high among pregnant women. Besides, the chance of developing type 2 diabetes is higher, especially three to six years after delivery. Moreover, exposure to hyperglycemia in the womb affects the health of children later, resulting in being overweight, making them more prone to developing type 2 diabetes in the coming years. Thus, it is projected to accentuate the market growth of type-2 diabetes in the forecasted period.

Global Type-2 Diabetes Market (2025-30): Regional Projection

Geographically, the Global Type-2 Diabetes Market expands across:

North America
South America
Europe
Middle East and Africa
Asia-Pacific

Here, North America captured a considerable market share in the Global Type-2 Diabetes market in 2024, with the US acquiring the majority market share in the region. It is primarily attributed to the surge in the rate of obesity, cardiovascular, and chronic diseases in the country, which has led to the growth of type-2 diabetes in people. According to the Centers for Disease Control and Prevention, diabetes negatively impacts around 37 million Americans, with type 2 diabetes accounting for 90-95% of cases. Type 2 diabetes affects predominantly those over the age of 45, along with a growing prevalence in adolescents, teenagers, and young adults.

On the other hand, an astronomical growth in the number of type-2 diabetes is anticipated in the Asia-Pacific region. The number of people with diabetes in Southeast Asia was 80 million in 2017 and is anticipated to surge to 151 million by the year 2045. Thus, these factors are projected to substantially contribute to the growth of the Type-2 Diabetes market in the coming years.

Global Type-2 Diabetes Industry Recent Development:

2024: Eli Lilly declared a total investment of $9 billion in its Lebanon, Indiana, manufacturing site. The site was expanded to produce APIs such as Zepbound (tirzepatide) injection and Mounjaro (tirzepatide) for the treatment of obesity and type 2 diabetes.

Gain a Competitive Edge with Our Global Type-2 Diabetes Market Report

Global Type-2 Diabetes Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
Global Type-2 Diabetes Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Frequently Asked Questions

A. The Type-2 Diabetes Market is expected to grow at a compound annual growth rate (CAGR) of 5.39% from 2025 to 2030.

A. The Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024.

A. Rising prevalence of obesity and sedentary lifestyles is expected to drive the global type-2 diabetes market during 2025-30.

A. Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson, and others are the leading players in the type-2 diabetes market.

A. Women segment held the largest share of the Type-2 Diabetes Market.

A. North America would present growth prospects in the Type-2 Diabetes Market during 2025-30.

A. Adoption of digital health and remote monitoring solutions is the key trend shaping the growth of the Type-2 Diabetes Market.

A. The development of personalized medicine and advanced therapies is the growth opportunity driving the Type-2 Diabetes Market.

Introduction
1. Research Process
2. Market Segmentation
3. Market Definition
4. Assumptions
Executive Summary
Expert Verbatim
Impact of Covid-19
1. Short Term Impact
2. Long Term Impact
Global Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
    1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    2. Alpha-glucosidase Inhibitors
    3. Biguanides
    4. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
    5. Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
    6. Sulfonylureas
    7. Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
  2. By Gender
    1. Male
    2. Female
  3. By Age Group
    1. Upto 19 years
    2. 20 – 65 years
    3. Above 65 years
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Region
North America Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. The US Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Canada Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Mexico Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
South America Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. Brazil Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Argentina Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Europe Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. The UK Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Germany Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. France Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Italy Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
8. Spain Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
9. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Middle East & Africa Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. UAE
    2. Saudi Arabia
    3. South Africa
    4. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. UAE Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Saudi Arabia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. South Africa Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Asia-Pacific Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. South East Asia
    7. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. China Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. India Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Japan Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. South Korea Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
8. Australia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
9. South East Asia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
10. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Global Type 2 Diabetes Regulations, Product Standards
Global Type 2 Diabetes Value Chain Analysis
Consumer Behavior Analysis
1. Consumer Trends and Preferences
2. Factors Affecting Buying Decision
Global Type 2 Diabetes Market Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Type 2 Diabetes Market Hotspots & Opportunities
Global Type 2 Diabetes Market Trends & Insights
Global Type 2 Diabetes Price Analysis
Global Type 2 Diabetes Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Target Market
  3. Target Age Group
  4. Manufacturing Units
  5. Research & Development
  6. Strategic Alliances & Initiatives
2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Merck & Co
  2. AstraZeneca
  3. Novo Nordisk
  4. Bristol-Myers Squibb
  5. Eli Lilly
  6. Sanofi
  7. Boehringer Ingelheim
  8. Pfizer
  9. Takeda
  10. Biocon
  11. Johnson & Johnson
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying